Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Hermes Intelligence Launches to Redefine Pharma Data Solutions
CP Wire
Wednesday, April 16, 2025 - 1:49pm
tags:
clinical trials, data, intelligence
Bluebird, after exploring 2nd buyout offer, sticks with Carlyle and SK Capital deal
Fierce Pharma
Wednesday, April 16, 2025 - 11:40am
tags:
Bluebird Bio, M&A, private equity, Carlyle, SK Capital
CDC advisers weigh lower age recommendation for RSV vaccines
Marketscreener
Wednesday, April 16, 2025 - 11:39am
tags:
CDC, ACIP, RSV, vaccines, GSK, Pfizer, Moderna Therapeutics
Glycomine grabs $115M series C to fund phase 2 journey for rare genetic disorder drug
Fierce Biotech
Wednesday, April 16, 2025 - 11:34am
tags:
Glycomine, funding, clinical trials, GLM101
National Association of Attorneys General Urges Congress to Prohibit PBM-Owned Pharmacies
Drug Topics
Wednesday, April 16, 2025 - 11:32am
tags:
legal, PBMs, pharmacies, congress
As Bluesky continues to grow, opportunities abound for pharma brands
Medical Marketing and Media
Wednesday, April 16, 2025 - 11:30am
tags:
social media, pharma marketing, Big Pharma, Bluesky, Novartis, AstraZeneca, Bristol Myers Squibb
Abbott maintains profit forecast, invests $500 million in US amid tariffs
Yahoo/Reuters
Wednesday, April 16, 2025 - 11:23am
tags:
Abbott Labs, earnings, Medtech, tariffs
Norgine strengthens rare disease portfolio with acquisition of Theravia
Yahoo Finance
Wednesday, April 16, 2025 - 11:18am
tags:
M&A, Theravia, Norgine, Rare Diseases
A judge blocked the FDA’s plan to regulate LDTs. What now?
Medtech Dive
Wednesday, April 16, 2025 - 11:16am
tags:
Medtech, LDTs, FDA, legal, diagnostics
Health department layoffs may be illegal, experts say
BioPharma Dive
Wednesday, April 16, 2025 - 11:14am
tags:
HHS, layoffs, legal
Amid an onshoring push, Raleigh is poised to be pharma’s next manufacturing hub
Pharma Voice
Wednesday, April 16, 2025 - 11:14am
tags:
tariffs, drug manufacturing, North Carolina, Raleigh, onshoring
FDA clears first migraine DTx from Click Therapeutics
Pharmaphorum
Wednesday, April 16, 2025 - 11:11am
tags:
Click Therapeutics, Medtech, digital therapeutics, DTx, CT-132, migraines, episodic migraines, FDA
Trump signs executive action to lower drug prices
NPR
Tuesday, April 15, 2025 - 7:58pm
tags:
Donald Trump, drug pricing, Medicare
J&J CEO Duato Urges Tax Fix, Not Tariffs To Drive US Pharma Manufacturing
BioSpace
Tuesday, April 15, 2025 - 7:55pm
tags:
JNJ, Joaquin Duato, drug manufacturing, taxes, tariffs, Pharma CEOs
Why Pfizer Stock Topped the Market on Tuesday
Motley Fool
Tuesday, April 15, 2025 - 7:53pm
tags:
Pfizer, PF-07976016, obesity, clinical trials
Wearable Neuro Device Approved to Assist Rehab of Stroke & SCI
Medical Devices and Diagnostics Industry
Tuesday, April 15, 2025 - 7:51pm
tags:
Medtech, wearables, Neuvotion, neuromodulation, spinal cord injury, stroke
Leqembi is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
Stock Titan
Tuesday, April 15, 2025 - 7:49pm
tags:
Leqembi, Alzheimer's disease, Europe, Biogen, Eisai
Merck inks $493M biobucks deal to use Cyprumed's tech to create oral peptides
Fierce Biotech
Tuesday, April 15, 2025 - 7:40pm
tags:
Merck, biobucks, Cyprumed, drug delivery, peptides
GSK in breach for misleading prescription information on Omjjara, industry body says
Yahoo Finance
Tuesday, April 15, 2025 - 11:30am
tags:
GSK, Omjjara, pharma marketing, regulatory
Bristol Myers stumbles in bid to widen heart drug’s use
BioPharma Dive
Tuesday, April 15, 2025 - 11:29am
tags:
Bristol Myers Squibb, Camzyos, hypertrophic cardiomyopathy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.